price

NASDAQ · AVTX
Avalo Therapeutics, Inc.
Healthcare · Biotechnology
$16.07
Down-$0.09 (-0.58%)
Updated Sep 16, 2026, 2:18 PM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 220.35M
- P/E ratio
- -2.73
- Dividend yield
- 0.00%
- 52-week range
- $12.51 – $24.27
- Volume
- 1.1M
- Avg. volume
- 410.27K
Price performance
AVTX price history
1M range · 20 trading sessions · Daily adjusted prices
AVTX closed at $16.07 after 20 trading sessions, down 18.47% for the selected period.
- Last close
- $16.07
- Period change
- -18.47%
- Period low
- $16.07
- Period high
- $20.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $16.13 | $16.69 | $15.39 | $16.07 | 1.1M |
| Sep 14, 2026 | $16.43 | $16.53 | $16.12 | $16.18 | 908.42K |
| Sep 11, 2026 | $17.42 | $18.135 | $16.02 | $16.12 | 2.53M |
| Sep 10, 2026 | $17.92 | $18.05 | $17.15 | $17.18 | 913.75K |
| Sep 9, 2026 | $19.47 | $19.74 | $18.035 | $18.21 | 725.72K |
| Sep 8, 2026 | $19.01 | $20.49 | $18.95 | $19.71 | 779.7K |
| Sep 4, 2026 | $18.81 | $19.62 | $18.79 | $19.23 | 633.23K |
| Sep 3, 2026 | $19.57 | $19.57 | $18.73 | $19.00 | 674.04K |
| Sep 2, 2026 | $19.00 | $19.855 | $19.00 | $19.34 | 988.02K |
| Sep 1, 2026 | $19.19 | $19.70 | $18.85 | $18.95 | 606.64K |
| Aug 31, 2026 | $19.40 | $19.58 | $19.00 | $19.34 | 1.38M |
| Aug 28, 2026 | $19.87 | $20.175 | $19.54 | $19.59 | 738.28K |
| Aug 27, 2026 | $20.47 | $20.568 | $19.91 | $20.05 | 420.54K |
| Aug 26, 2026 | $19.74 | $20.94 | $19.61 | $20.55 | 813.99K |
| Aug 25, 2026 | $19.54 | $20.05 | $19.36 | $19.74 | 1.02M |
| Aug 24, 2026 | $19.86 | $19.86 | $18.88 | $19.27 | 759.04K |
| Aug 21, 2026 | $20.02 | $20.19 | $19.58 | $19.83 | 569.83K |
| Aug 20, 2026 | $20.38 | $20.59 | $19.49 | $19.82 | 698.46K |
| Aug 19, 2026 | $20.41 | $21.02 | $20.14 | $20.75 | 999.05K |
| Aug 18, 2026 | $19.91 | $20.46 | $19.62 | $19.71 | 1.07M |
Latest AVTX news
The latest Smart Investors Daily articles mentioning AVTX.
Stock researchResearch & News · SEC Filings
Loading stock research…

